Muramoto Akiko, Matsushita Madoka, Kato Ayako, Yamamoto Naoki, Koike George, Nakamura Masakazu, Numata Takeyuki, Tamakoshi Akiko, Tsushita Kazuyo
Division of Health Development of Comprehensive Health Science Center, Aichi Health Promotion Foundation, 1-1 Gengoyama, Morioka, Higashiura-cho, 470-2101 Aichi-ken, Japan.
Division of Health Development of Comprehensive Health Science Center, Aichi Health Promotion Foundation, 1-1 Gengoyama, Morioka, Higashiura-cho, 470-2101 Aichi-ken, Japan; Toyota Motor Corporation, Japan.
Obes Res Clin Pract. 2014 Sep-Oct;8(5):e466-75. doi: 10.1016/j.orcp.2013.10.003. Epub 2013 Nov 5.
Adequate goal-setting is important in health counselling and treatment for obesity and overweight. We tried to determine the minimum weight reduction required for improvement of obesity-related risk factors and conditions in obese and overweight Japanese people, using a nationwide intervention programme database.
Japanese men and women (n=3480; mean age±standard deviation [SD], 48.3±5.9 years; mean body mass index±SD, 27.7±2.5kgm(-2)) with "Obesity Disease" or "Metabolic Syndrome" participated in a 6-month lifestyle modification programme (specific health guidance) and underwent follow-up for 6 months thereafter. The relationship between percent weight reduction and changes in 11 parameters of obesity-related diseases were examined.
Significant weight reduction was observed 6 months after the beginning of the programme, and it was maintained for 1 year. Concomitant improvements in parameters for obesity-related diseases were also observed. One-third of the subjects reduced their body weight by ≥3%. In the group exhibiting 1% to <3% weight reduction, plasma triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), haemoglobin A1c (HbA1c), aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transpeptidase (γ-GTP) decreased significantly, and high-density lipoprotein cholesterol (HDL-C) increased significantly compared to the control group (±1% weight change group). In addition to the improvements of these 7 parameters (out of 11), significant reductions in systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting plasma glucose (FPG) and uric acid (UA) (total 11 of 11 parameters) were observed in the group with 3% to <5% weight reduction. In the group with ≥5% weight reduction, the same 11 parameters also improved as those in the group with 3% to <5% weight reduction.
The 6-month lifestyle modification programme induced significant weight reduction and significant improvement of parameters of obesity-related diseases. All the measured obesity-related parameters were significantly improved in groups with 3% to <5% and ≥5% weight reduction. Based on these findings, the minimum weight reduction required for improvement of obesity-related risk factors or conditions is 3% in obese and overweight (by WHO classification) Japanese people.
在肥胖和超重的健康咨询及治疗中,设定适当的目标很重要。我们试图利用一个全国性干预项目数据库,确定肥胖和超重的日本人改善肥胖相关危险因素及状况所需的最小体重减轻幅度。
患有“肥胖症”或“代谢综合征”的日本男性和女性(n = 3480;平均年龄±标准差[SD],48.3±5.9岁;平均体重指数±SD,27.7±2.5kg/m²)参加了为期6个月的生活方式改善项目(特定健康指导),并在之后接受了6个月的随访。研究了体重减轻百分比与肥胖相关疾病11项参数变化之间的关系。
项目开始6个月后观察到显著的体重减轻,并持续了1年。同时还观察到肥胖相关疾病参数的改善。三分之一的受试者体重减轻了≥3%。在体重减轻1%至<3%的组中,与对照组(体重变化±1%组)相比,血浆甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、糖化血红蛋白(HbA1c)、天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)和γ-谷氨酰转肽酶(γ-GTP)显著降低,高密度脂蛋白胆固醇(HDL-C)显著升高。除了这7项参数(共11项)得到改善外,在体重减轻3%至<5%的组中,收缩压(SBP)、舒张压(DBP)、空腹血糖(FPG)和尿酸(UA)(共11项参数全部)也显著降低。在体重减轻≥5%的组中,与体重减轻3%至<5%的组一样,这11项参数也得到了改善。
为期6个月的生活方式改善项目导致了显著的体重减轻以及肥胖相关疾病参数的显著改善。在体重减轻3%至<5%和≥5%的组中,所有测量的肥胖相关参数均得到显著改善。基于这些发现,肥胖和超重(根据世界卫生组织分类)的日本人改善肥胖相关危险因素或状况所需的最小体重减轻幅度为3%。